Health Dictionary Find a Doctor

R-DHAOx regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

Overview

R-DHAOx regimen refers to a regimen consisting of rituximab, dexamethasone, high-dose cytarabine (Ara-C), and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin’s lymphoma.^[1]

Regimen

Regimen

RRituximab

DDexamethasone

HHigh Dose

ACytarabine (Ara-C)

OxOxaliplatin

Indications

Indications

Follicular non-Hodgkin’s lymphoma^[1]

References

References

↑ ^1.0 ^1.1 Machover D, Delmas-Marsalet B, Misra SC, Ulusakarya A, Gumus Y, Frénoy N; et al. (2010). “Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin’s lymphoma”. Biomed Pharmacother. 64 (2): 83–7. doi:10.1016/j.biopha.2009.11.001. PMID 20044233.

Looking for the patient version?

Back to the patient-friendly article

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH